Sign in:
Email
 Password  save:
  
 Company Reports 
 
   
My Recent Searches
  Help
 
   
 
 
Get Insiders for : 
Hoth Therapeutics, Inc. (HOTH)  
$0.00 0.00 (0.00%) as of 4:30 Fri 2/14


Download
   
Exchange: N/A
Security Type: Common
Shares Out: 3,441,000
Market Cap: N/A
Last Volume: 0 Avg Vol: 0
52 Week Range: $0 - $0
Level I Sector: N/A
Level II Sector: N/A
Level III Sector: N/A

Member Indexes:

   

Rankings:

     
Insider 3 Months    :   -
Insider 6 Months    :   -
Insider 3/6 Months :   -
Guru Rank Number :  -
Guru Rank Value     :  -
Guru Occurances    :  -

 

                 
 
Company Profile   Hoth Therapeutics is a clinical-stage biopharmaceutical company focused on developing therapies for unmet medical needs. Co. is focused on developing a topical formulation for treating side effects from drugs used for the treatment of cancer (HT-001); a treatment for mast-cell derived cancers and anaphylaxis (HT-KIT); and a treatment and/or prevention for Alzheimer's or other neuroinflammatory diseases (HT-ALZ). In addition, Co. is developing a diagnostic device via a mobile device. Co. also has interests in certain other assets being developed by third parties including HT-005 for patients with lupus and potential product candidates being developed for the prevention of COVID-19.


 
 
Summary  (Direct Transactions Only) 3 Months 6 Months 12 Months 24 Months
Total Shares Bought 0 0 0 20,000
Total Buy Value $0 $0 $0 $7,900
Total People Bought 0 0 0 1
Total Buy Transactions 0 0 0 2
Total Shares Sold 0 0 0 0
Total Sell Value $0 $0 $0 $0
Total People Sold 0 0 0 0
Total Sell Transactions 0 0 0 0
End Date 2024-02-15 2023-11-14 2023-05-16 2022-05-16

   
Records found: 11
  Page 1 of 1  
Filer's Name Relation Title Off-Dir-10% Tran. Date Form Action Price Mkt Value D/I Shares Holdings
Rank

 
3m +/-  
Form
   Pavell Jeff Director   –       •      –    2022-12-13 4 A $0.00 $0 D/D 5,075 5,075     -
   Knie Robb CEO and President   •       •      –    2022-09-19 4 B $0.39 $3,900 D/D 10,000 828,259 2.73     -
   Knie Robb CEO and President   •       •      –    2022-09-16 4 B $0.40 $4,000 D/D 10,000 818,259 2.73     -
   Hayes Anthony Former Director   –       –      –    2020-05-26 4/A S $0.00 $0 D/D (0) 0     -
   Hayes Anthony 10% Owner   –       –       •   2020-05-26 4 S $1.25 $500,000 D/D (400,000) 1,130,674     -
   Linsley Wayne Director   –       •      –    2020-04-15 4 A $0.00 $0 D/D 3,333 3,333     -
   Springer Graig Director   –       •      –    2020-04-15 4 A $0.00 $0 D/D 3,333 3,333     -
   Eitner Matthew D. 10% Owner   –       –       •   2019-02-20 4 A $0.00 $0 D/D 15,000 765,000     -
   Poor Kevin Jess 10% Owner   –       –       •   2019-02-20 4 A $0.00 $0 D/D 750,000 750,000     -
   Ahern James P. 10% Owner   –       –       •   2019-02-14 3 IO $0.00 $0 D/D 0 750,000     -
   Eitner Matthew D. 10% Owner   –       –       •   2019-02-14 3 IO $0.00 $0 D/D 0 750,000     -

  11 Records found
  1    
  Page 1 of 1
  Transaction Code Key: Ownership Code Key
  B - Buy AB - Automatic Buy D - Direct Ownership
  S - Sell AS - Automatic Sell I - Indirect Ownership
  OE - Options Exercised A - Acquired
  IO - Initital Ownership D - Disposed